Great achievement in Sweden
For the first time the Award “Patients Advocate of The Year” was presented in Stockholm, Sweden by the organisation Fokus Patient.
Among several very large patient organisations, such as Asthma- and Allergy Association and Swedish Breast Cancer Association – our young and comparatively very small organisation was awarded a very honorable second place! We are so proud!
In the motivation says that Riksföreningen för systemisk skleros [Swedish Scleroderma Patient Organisation] through hard work have been creating contacts with both authorities and politicians which has resulted in changes in the care of patient with scleroderma.
Well, we are not at all satisfied yet and will continue to fight!
Monica Holmner,
Riksföreningen för systemisk skleros
news & events
2022 highlights
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
This is Living!
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.